The above evidence, together with our GWAS findings, may prompt us to propose a hypothetical mechanism for co-regulation of obesity and osteoporosis, where the SOX6 gene's effects on chondrocytes and pancreatic beta cells may play a key role. The gene discussed is SOX6; the disease is obesity due to melanocortin 4 receptor deficiency.